Advertisement

Topics

Maricann Group Inc. Signs Letter of Intent with Lovell Drugs

00:30 EST 13 Nov 2017 | BioMedReports - Blog

TORONTO, ONTARIO--(Marketwired - Nov. 13, 2017) -

Not for dissemination or distribution in the United States or through U.S. newswire services.

Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)

Read more...

Original Article: Maricann Group Inc. Signs Letter of Intent with Lovell Drugs

NEXT ARTICLE

More From BioPortfolio on "Maricann Group Inc. Signs Letter of Intent with Lovell Drugs"

Advertisement
Quick Search
Advertisement
Advertisement